Furthermore, through a comparative analysis of the diagnostic efficacy of APT (Apo10 and TKTL1) with that of conventional markers, we discovered that APT’s sensitivity in detecting breast cancer surpassed that of other traditional tumor markers. This evidence concerns the gene TKTL1 and breast carcinoma.